Showing results (161-170 of 220) with videos related to

Sort By:
Pageof 22
Journal of Bioscience and Bioengineering|July 3, 2013
Identification of a candidate single-nucleotide polymorphism related to chemotherapeutic response through a combination of knowledge-based algorithm and hypothesis-free genomic dataHiro Takahashi, Nahoko Kaniwa, Yoshiro Saito, et al.
Oncotarget|December 10, 2017
The peripheral immune status of granulocytic myeloid-derived suppressor cells correlates the survival in advanced gastric cancer patients receiving cisplatin-based chemotherapyHirokazu Shoji, Kohei Tada, Shigehisa Kitano, et al.
Surgery|November 23, 2017
Disentangling the prognostic heterogeneity of stage III colorectal cancer through histologic stromal categorizationHideki Ueno, Shigeki Sekine, Taihei Oshiro, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 5, 2008
Close association of UGT1A9 IVS1+399C>T with UGT1A1*28, *6, or *60 haplotype and its apparent influence on 7-ethyl-10-hydroxycamptothecin (SN-38) glucuronidation in JapaneseYoshiro Saito, Kimie Sai, Keiko Maekawa, et al.
BMC Cancer|October 18, 2015
Construction of possible integrated predictive index based on EGFR and ANXA3 polymorphisms for chemotherapy response in fluoropyrimidine-treated Japanese gastric cancer patients using a bioinformatic methodHiro Takahashi, Nahoko Kaniwa, Yoshiro Saito, et al.
Oncology|October 30, 2017
Patterns of Relapse after Definitive Chemoradiotherapy in Stage II/III (Non-T4) Esophageal Squamous Cell CarcinomaKazuki Sudo, Ken Kato, Hiroki Kuwabara, et al.
Pharmacogenetics and Genomics|June 15, 2007
Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A1*6 and *28Hironobu Minami, Kimie Sai, Mayumi Saeki, et al.
Oncotarget|May 10, 2014
Biomarkers of reactive resistance and early disease progression during chemotherapy plus bevacizumab treatment for colorectal carcinomaHidetoshi Hayashi, Tokuzo Arao, Kazuko Matsumoto, et al.
The Journal of Dermatology|June 12, 2025
Facial Skin With Conspicuous Enlarged Pores Closely Related to Severity of Facial Acneiform Rash and Therapeutic Effects of EGFR Inhibitors in RAS Wild-Type Metastatic Colorectal Cancer: Ancillary Analysis of FAEISS Study (NCCH1512)Shusuke Yoshikawa, Katsuko Kikuchi, Keiko Nozawa, et al.
Clinical Colorectal Cancer|November 25, 2017
A Prospective, Multicenter Phase II Study of the Efficacy and Feasibility of 15-minute Panitumumab Infusion Plus Irinotecan for Oxaliplatin- and Irinotecan-refractory, KRAS Wild-type Metastatic Colorectal Cancer (Short Infusion of Panitumumab Trial)Kohei Akiyoshi, Tetsuya Hamaguchi, Kenichi Yoshimura, et al.
Pageof 22